194 related articles for article (PubMed ID: 9276138)
1. Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs.
Longmore J; Hill RG; Hargreaves RJ
Can J Physiol Pharmacol; 1997 Jun; 75(6):612-21. PubMed ID: 9276138
[TBL] [Abstract][Full Text] [Related]
2. Tachykinin receptors and receptor subtypes.
Patacchini R; Maggi CA
Arch Int Pharmacodyn Ther; 1995; 329(1):161-84. PubMed ID: 7639617
[TBL] [Abstract][Full Text] [Related]
3. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
Patacchini R; Barthó L; Maggi CA
Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
[TBL] [Abstract][Full Text] [Related]
4. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
[TBL] [Abstract][Full Text] [Related]
5. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences.
Belvisi MG; Patacchini R; Barnes PJ; Maggi CA
Br J Pharmacol; 1994 Jan; 111(1):103-10. PubMed ID: 7516799
[TBL] [Abstract][Full Text] [Related]
6. The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough.
Advenier C; Lagente V; Boichot E
Eur Respir J; 1997 Aug; 10(8):1892-906. PubMed ID: 9272936
[TBL] [Abstract][Full Text] [Related]
7. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
Meini S; Patacchini R; Maggi CA
Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
[TBL] [Abstract][Full Text] [Related]
8. The mammalian tachykinin receptors.
Maggi CA
Gen Pharmacol; 1995 Sep; 26(5):911-44. PubMed ID: 7557266
[TBL] [Abstract][Full Text] [Related]
9. Tachykinin receptors mediating responses to sensory nerve stimulation and exogenous tachykinins and analogues in the rabbit isolated iris sphincter.
Hall JM; Mitchell D; Morton IK
Br J Pharmacol; 1993 Aug; 109(4):1008-13. PubMed ID: 8401912
[TBL] [Abstract][Full Text] [Related]
10. Tachykinins and neuropsychiatric disorders.
Chahl LA
Curr Drug Targets; 2006 Aug; 7(8):993-1003. PubMed ID: 16918327
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
Picard P; Regoli D; Couture R
Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
[TBL] [Abstract][Full Text] [Related]
12. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
[TBL] [Abstract][Full Text] [Related]
13. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
[TBL] [Abstract][Full Text] [Related]
14. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
15. Tachykinins and tachykinin receptors in bone.
Goto T; Tanaka T
Microsc Res Tech; 2002 Jul; 58(2):91-7. PubMed ID: 12203708
[TBL] [Abstract][Full Text] [Related]
16. Substance P and its receptors -- a potential target for novel medicines in malignant brain tumour therapies (mini-review).
Łazarczyk M; Matyja E; Lipkowski A
Folia Neuropathol; 2007; 45(3):99-107. PubMed ID: 17849359
[TBL] [Abstract][Full Text] [Related]
17. Tachykinin receptors as therapeutic targets in stress-related disorders.
Ebner K; Sartori SB; Singewald N
Curr Pharm Des; 2009; 15(14):1647-74. PubMed ID: 19442179
[TBL] [Abstract][Full Text] [Related]
18. Tachykinin receptor inhibition and c-Fos expression in the rat brain following formalin-induced pain.
Baulmann J; Spitznagel H; Herdegen T; Unger T; Culman J
Neuroscience; 2000; 95(3):813-20. PubMed ID: 10670449
[TBL] [Abstract][Full Text] [Related]
19. Potencies of agonists acting at tachykinin receptors in the oestrogen-primed rat uterus: effects of peptidase inhibitors.
Fisher L; Pennefather JN
Eur J Pharmacol; 1997 Sep; 335(2-3):221-6. PubMed ID: 9369377
[TBL] [Abstract][Full Text] [Related]
20. Development and potential utility of dual and triple NK receptor antagonists.
Rizzo CA; Anthes JC; Corboz MR; Chapman RW; Shih NY; Reichard GA; Ng KJ; Hey JA
Curr Top Med Chem; 2003; 3(12):1410-22. PubMed ID: 12871172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
